Through the integration of network toxicology, multi-omics analyses, a comprehensive assessment of 101 machine-learning algorithms, and subsequent in vitro validation, this research definitively establishes PLK1 as a key mediator of EDs-aggravated prostate cancer malignancy. Here, PLK1 is linked to prostate carcinoma.